Efficacy and Safety of Tadalafil in Hemodialysis Patients
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to check the safety and efficacy of a pde5 inhibitor, tadalafil,
is a special group of patients: Renal chronic patients in hemodialysis treatment.